Nucleic Acids Research, 1989, Vol. 17, No. 24 10231-10241
© 1989
Articles |
Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH)
-globulin promoter
Dipartimento di Genetica e di Biologia dei Microrganismi, Universita di Milano Italy 1Dipartimento di Genetica, Biologia e Chimica Medica, Università di Torino Italy
*To Whom Correspondance should be addressed
Received October 2, 1989. Revised November 22, 1989. Accepted November 22, 1989.
The
198 T
C mutation in the promoter of the A
-globin gene increases 2030 fold the expression of this gene in adult erythroid cells of patients (Hereditary Persistence of Fetal Hemoglobin, HPFH). We show here that this mutation creates a strong binding site, resembling a CACCC box, for two ubiquitous nuclear proteins, one of which is Spl. The mutated promoter is four to five-fold more efficient than a normal
globin promoter in driving expression of a CAT reporter plasmid when transfected into erythroid cells. The overexpression of the mutant is abolished by the introduction of an additional mutation disrupting the new binding site. No overexpression of the mutant is observed in non-erythroid cells, indicating that the ubiquitous factors bound on the mutated sequence must cooperate with erythroid specific factors.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. A. Olave, C. Doneanu, X. Fang, G. Stamatoyannopoulos, and Q. Li Purification and Identification of Proteins That Bind to the Hereditary Persistence of Fetal Hemoglobin -198 Mutation in the {gamma}-Globin Gene Promoter J. Biol. Chem., January 12, 2007; 282(2): 853 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Catena, C. Tiveron, A. Ronchi, S. Porta, A. Ferri, L. Tatangelo, M. Cavallaro, R. Favaro, S. Ottolenghi, R. Reinbold, et al. Conserved POU Binding DNA Sites in the Sox2 Upstream Enhancer Regulate Gene Expression in Embryonic and Neural Stem Cells J. Biol. Chem., October 1, 2004; 279(40): 41846 - 41857. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Testa, F. Lotti, L. Cairns, A. Grande, S. Ottolenghi, G. Ferrari, and A. Ronchi Deletion of a Negatively Acting Sequence in a Chimeric GATA-1 Enhancer-Long Terminal Repeat Greatly Increases Retrovirally Mediated Erythroid Expression J. Biol. Chem., March 12, 2004; 279(11): 10523 - 10531. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jacquelin, M. D. Tarantino, M. Kritzik, D. Rozenshteyn, J. A. Koziol, A. T. Nurden, and T. J. Kunicki Allele-dependent transcriptional regulation of the human integrin {alpha}2 gene Blood, March 15, 2001; 97(6): 1721 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Ronchi, S. Bottardi, C. Mazzucchelli, S. Ottolenghi, and C. Santoro Differential Binding of the NFE3 and CP1/NFY Transcription Factors to the Human [IMAGE]- and [IMAGE]-Globin CCAAT Boxes J. Biol. Chem., September 15, 1995; 270(37): 21934 - 21941. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Minie, T Kimura, and G Felsenfeld The developmental switch in embryonic rho-globin expression is correlated with erythroid lineage-specific differences in transcription factor levels Development, January 8, 1992; 115(4): 1149 - 1164. [Abstract] [PDF] |
||||


